Panbela Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nant Capital, LLC(33.33%),Patrick Soon-Shiong(33.33%)
Panbela Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Nant Capital, LLC
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horvath Susan
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.
Panbela Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.
Panbela Therapeutics | D: Filing D
Panbela Therapeutics | D: Filing D
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GOLDMAN SACHS GROUP INC
Panbela Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner GOLDMAN SACHS GROUP INC
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jacob Jeffrey E.
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horvath Susan
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cullen Michael T.
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Donovan Daniel
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fratamico Arthur
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jacob Jeffrey E.
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MATHIESEN JEFFREY S
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schemel Donald Robert
Panbela Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael T. Cullen(3.3%)
Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data
No Data